Bone Marrow Failure Syndromes -II | Hematology Animation | Medicine | V-Learning скачать в хорошем качестве

Bone Marrow Failure Syndromes -II | Hematology Animation | Medicine | V-Learning

In this Hematology Medicine lecture, Bone Marrow Failure Syndromes - II, myelodysplasia and myelophthisic anemias are discussed in terms of their classification, causes, pathogenesis, clinical features, differential diagnosis, and treatment. ▬ 📌 Myelodysplasia Myelodysplasia is a rare blood cancer that affects the bone marrow's ability to produce healthy blood cells, leading to a shortage of red blood cells, white blood cells, and platelets. This can result in anemia, infections, and bleeding disorders, among other symptoms. ▬ 📌 Classification of Myelodysplasia Refractory cytopenias and refractory anemia are two subtypes of myelodysplasia, which are based on the types of blood cells affected and the degree of cytopenia (insufficient cell production). 👉 Refractory cytopenias This subtype is characterized by low blood counts in two or more cell lines, including red blood cells, white blood cells, or platelets. The bone marrow shows abnormal morphology of blood cells, but the number of blasts is less than 5%. 👉 Refractory anemia This subtype is characterized by low red blood cell counts and abnormal morphology of red blood cells in the bone marrow and blood. The number of blasts in the bone marrow is less than 5%. Myelodysplasia is thought to be caused by various factors that lead to stem cell dysfunction, including genetic mutations, exposure to toxins such as chemotherapy or radiation, and age-related changes in the bone marrow. ▬ 📌 Pathogenesis and Diagnosis The pathogenesis of myelodysplasia involves the abnormal maturation of blood cells, leading to their early death or a block in their differentiation. This results in a range of clinical features, including anemia, infections, bleeding disorders, and enlarged spleen or liver, which can be detected through physical examination. Diagnosis of myelodysplasia requires blood and bone marrow samples to be examined for abnormal blood cell morphology, chromosome abnormalities, and genetic mutations. Laboratory tests for myelodysplasia include complete blood count, blood film examination, bone marrow biopsy, and cytogenetic analysis. ▬ 📌 Differential Diagnosis of Myelodysplasia Myelodysplasia must be differentiated from other conditions that cause similar symptoms, including aplastic anemia, acute myeloid leukemia, chronic myeloid leukemia, myeloproliferative disorders, and paroxysmal nocturnal hemoglobinuria. Now let’s discuss Myelophthisic anemia. ▬ 📌 Myelophthisic anemias Myelophthisic anemias are a group of conditions that result from the replacement of normal bone marrow tissue with non-hematopoietic or abnormal cells, leading to bone marrow failure and anemia. Here is an overview of the pathophysiology, clinical features, diagnosis, and treatment of myelophthisic anemias: ▬ 📌 Pathophysiology & Clinical features Myelophthisic anemias can be caused by a variety of conditions that infiltrate the bone marrow, such as metastatic cancer, myelofibrosis, granulomatous diseases, and other hematologic disorders. These conditions displace normal hematopoietic cells and interfere with their production, leading to reduced numbers of red blood cells, white blood cells, and platelets. The clinical features of myelophthisic anemia depend on the underlying cause and the extent of bone marrow infiltration. Common symptoms include fatigue, weakness, pallor, shortness of breath, bruising or bleeding, and recurrent infections. Other symptoms may also occur, depending on the underlying condition. ▬ 📌 Diagnosis & Treatment Diagnosis of myelophthisic anemias typically involves a complete blood count (CBC) to measure blood cell counts and morphology, along with a bone marrow biopsy to assess the degree of bone marrow infiltration and the underlying cause. Additional tests may be necessary to confirm the diagnosis and identify the specific underlying condition, such as imaging studies or serologic tests. The treatment of myelophthisic anemia depends on the underlying cause and severity of symptoms. Treatment may include addressing the underlying condition, such as chemotherapy for cancer, or supportive measures to manage anemia, such as blood transfusions, erythropoietin-stimulating agents, or iron supplementation. In some cases, a bone marrow transplant may be necessary to replace the damaged bone marrow with healthy stem cells. ▬ 🎬 5500+ sqadia.com Medical Videos ▬▬▬▬▬▬▬▬▬▬ 👩🏻‍⚕️ Accessible Medical Student Education 24/7/365 💡 Simplifying Medical Learning 💪 Study Hard, Dream Big, Achieve More